InvestorsHub Logo
Followers 23
Posts 667
Boards Moderated 0
Alias Born 06/28/2010

Re: None

Sunday, 11/30/2014 11:28:41 PM

Sunday, November 30, 2014 11:28:41 PM

Post# of 403741
Some news that may be of interest to those who are agreeable to the idea of Kevetrin combined with existing cancer drugs:
*************************************************************
Dr Reddy's Laboratories launches Docetaxel injection in US

Nov 24, 2014

HYDERABAD: Dr Reddy's Laboratories has launched Docetaxel injection USP 20 mg/mL and 80 mg/4 mL, a generic version of Taxotere (docetaxel injection) in the US market.

Dr Reddy's Abbreviated New Drug Application (ANDA) is approved by the United States Food & Drug Administration ( USFDA), DRL said in a statement today.

http://articles.economictimes.indiatimes.com/2014-11-24/news/56420833_1_states-food-drug-administration-dr-reddy-ims-health-data
*******************************************************************
The idea here being - combine Kevetrin with a proven generic to keep costs down for patients, and add Kevetrin to improve outcomes and reduce side effects. Leo and Dr. Menon would probably feel at home working with Dr. Reddy's in such a relationship. IMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News